Koers RavenQuest BioMed Inc. Canadian Securities Exchange
Aandelen
RQB
CA7543871080
Bedrijfsondersteunende diensten
Omzet 2017 | 0,11 0,15 0,11 | Omzet 2018 | 1,26 1,72 1,18 | Marktkapitalisatie | 58,71 mln. 80,25 mln. 54,91 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2017 | -3 mln. -4,1 mln. -2,81 mln. | Nettowinst (verlies) 2018 | -30 mln. -41,01 mln. -28,06 mln. | EV/omzet 2017 * | - |
Nettoliquiditeiten 2017 | 3,15 mln. 4,3 mln. 2,94 mln. | Nettoschuld 2018 | 12,9 mln. 17,63 mln. 12,06 mln. | EV/omzet 2018 | 56.975.119 x |
K/w-verhouding 2017 * |
-
| K/w-verhouding 2018 |
-1,55
x | Werknemers | - |
Dividendrendement 2017 * |
-
| Dividendrendement 2018 |
-
| Vrij verhandelbaar | 89,48% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Jay Dhaliwal
CEO | Chief Executive Officer | 36 | 27-11-19 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Jay Dhaliwal
CEO | Chief Executive Officer | 36 | 27-11-19 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+6,13% | 7,41 mld. | |
-32,64% | 3,24 mld. | |
+11,38% | 1,75 mld. | |
-9,32% | 1,08 mld. | |
+31,69% | 907 mln. | |
-7,64% | 714 mln. | |
-3,60% | 606 mln. | |
-8,30% | 539 mln. | |
-22,29% | 515 mln. |